Abstract: The present invention is directed to a method of preventing cancer or preventing the recurrence of cancer after undergoing a cancer treatment by administering a composition comprising at least one of ?-tocotrienol or ?-tocotrienol, wherein the cancer is selected from the group consisting of melanoma, prostate cancer, prostate intraepithelial neoplasia, colon cancer, liver cancer, bladder cancer, breast cancer and lung cancer. The present invention is further directed to a composition comprising at least one of ?-tocotrienol or ?-tocotrienol and Docetaxel and/or Dacarbazine, and to a method of inhibiting or arresting or reversing of cancer by administering a composition comprising at least one of ?-tocotrienol or ?-tocotrienol together with Docetaxel and/or Dacarbazine. The present invention is also directed to methods of manufacturing those compositions.

Abstract: This invention provides a method for determining whether a subject is afflicted with Benign Prostate Hyperplasia (BPH) comprising obtaining a sample of prostatic fluid from the subject and analyzing the sample of prostatic fluid to detect the presence of BPH protein markers to determine whether the subject is afflicted with BPH. This invention further provides a method for determining whether a subject is afflicted with Benign Prostate Hyperplasia (BPH) comprising obtaining a serum sample from the subject and analyzing the serum sample to detect the presence of BPH protein markers to determine whether the subject is afflicted with BPH. Finally, this invention provides a diagnostic kits for detecting Benign Prostate Hyperplasia (BPH) markers comprising BPH protein markers and instructions for use.